SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3rd mRNA Vaccine Dose

Alexa J. Roeder, Megan A. Koehler, Sergei Svarovsky, Paniz Jasbi, Alim Seit-Nebi, Maria J. Gonzalez-Moa, John Vanderhoof, Davis McKechnie, Baylee A. Edwards, Douglas F. Lake
doi: https://doi.org/10.1101/2022.03.03.22270812

Article usage

Article usage: March 2022 to June 2025

AbstractFullPdf
Mar 2022293027469
Apr 202223814673
May 20221741624
Jun 2022119010
Jul 202291112
Aug 20228327
Sep 202275813
Oct 202265110
Nov 20223906
Dec 20222327
Jan 202326110
Feb 20232938
Mar 20233403
Apr 20232514
May 20231726
Jun 20231162
Jul 2023722
Aug 202320104
Sep 20232156
Oct 20231948
Nov 20231503
Dec 20232026
Jan 20241503
Feb 20241839
Mar 2024715
Apr 20241158
May 20241026
Jun 20241524
Jul 20241158
Aug 202415714
Sep 20242365
Oct 20241254
Nov 202424617
Dec 2024725
Jan 20251588
Feb 20251796
Mar 2025311515
Apr 202530113
May 202522516
Jun 2025391312
Back to top
Posted March 06, 2022.
Download PDF

Supplementary Material

Data/Code
Email
SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3rd mRNA Vaccine Dose
Alexa J. Roeder, Megan A. Koehler, Sergei Svarovsky, Paniz Jasbi, Alim Seit-Nebi, Maria J. Gonzalez-Moa, John Vanderhoof, Davis McKechnie, Baylee A. Edwards, Douglas F. Lake
medRxiv 2022.03.03.22270812; doi: https://doi.org/10.1101/2022.03.03.22270812
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area